Bennison, C., Stephens, S., Lescrauwaet, B., Van Hout, B., & Jackson, T. L. (2016). Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole. J Mark Access Health Policy.
Dyfyniad Arddull ChicagoBennison, Craig, Stephanie Stephens, Benedicte Lescrauwaet, Ben Van Hout, and Timothy L. Jackson. "Cost-effectiveness of Ocriplasmin for the Treatment of Vitreomacular Traction and Macular Hole." J Mark Access Health Policy 2016.
Dyfyniad MLABennison, Craig, et al. "Cost-effectiveness of Ocriplasmin for the Treatment of Vitreomacular Traction and Macular Hole." J Mark Access Health Policy 2016.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.